Relpax and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Levaquin (levofloxacin). Common drug interactions include gait deviation among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Levaquin. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

On Jul, 30, 2026

99 people who take Relpax and Levaquin together, and have interactions are studied.

What are the common drug interactions of Relpax and Levaquin, by gender? *:

female:

Gait deviation
Gallbladder disorder
Hypersensitivity
Hypersomnia (excessive daytime sleepiness (eds))
Influenza
Lumbar radiculopathy (radicular pain in the low back and legs)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Insomnia (sleeplessness)
Anxiety

male:

Chronic kidney disease
Emotional disorder
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Drug hypersensitivity
Eye infection
Joint injury
Liver disorder (liver diseases)
Nephrogenic anaemia (anaemia due to kidney disease)
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Postoperative wound infection

What are the common drug interactions of Relpax and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain
Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
Diarrhoea
Dizziness
Haematemesis (vomiting of blood)
Haematochezia (passage of stools containing blood)
Nausea (feeling of having an urge to vomit)
Vomiting
Gallbladder injury

20-29:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Insomnia (sleeplessness)
Alopecia (absence of hair from areas of the body)
Anxiety
Breast pain
Epistaxis (bleed from the nose)
Nausea (feeling of having an urge to vomit)
Rash
Urinary tract infection
Depression

30-39:

Asthma
Headache (pain in head)
Oral herpes (viral infection of mouth)
Weight increased
Insomnia (sleeplessness)
Abdominal pain upper
Arthralgia (joint pain)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Bone loss
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

40-49:

Osteomalacia (softening of the bones due to a lack of vitamin d)
Pain
Postictal state
Pulmonary embolism (blockage of the main artery of the lung)
Quality of life decreased
Rash
Streptococcal infection
Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
Weight decreased
Arthralgia (joint pain)

50-59:

Dyspnoea (difficult or laboured respiration)
Cardiac arrest
Chronic kidney disease
Limb injury
Renal failure (kidney dysfunction)
Road traffic accident
Anaphylactic reaction (serious allergic reaction)
Asthma
Blood pressure increased
Chest discomfort

60+:

Drug hypersensitivity
Emotional disorder
Liver disorder (liver diseases)
Muscular weakness (muscle weakness)
Nephrogenic anaemia (anaemia due to kidney disease)
Nervousness
Pain in extremity
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 20 people, 20.20%
Birth Control: 14 people, 14.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 11.11%
Pain: 10 people, 10.10%
Asthma: 10 people, 10.10%
Insomnia (sleeplessness): 9 people, 9.09%
Immunodeficiency Common Variable: 9 people, 9.09%
Depression: 8 people, 8.08%
Nausea (feeling of having an urge to vomit): 7 people, 7.07%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.07%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously